Using state-of-the-art technology and techniques, EMBL's Müller group has provided the most detailed structure to date of human RNA polymerase I (Pol I), offering fundamental information about cellular function for those studying rare diseases and cancers. RNA Pol I has been implicated in certain disorders and cancers.